Barinthus Biotherapeutics (BRNS)
NASDAQ: BRNS
· Real-Time Price · USD
1.27
0.03 (2.42%)
At close: Aug 18, 2025, 10:57 AM
Barinthus Biotherapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -59.62M | -55.44M | -52.38M | -63.83M | -70.7M | -73.45M | -77.32M | -54.99M | -15.48M | 5.32M | 11.31M | -1.48M | -33.15M | -51.11M | -46.47M | -41.7M | -29.37M |
Depreciation & Amortization | 6.41M | 5.8M | 5.81M | 5.81M | 5.64M | 5.43M | 5.17M | 4.88M | 4.58M | 4.32M | 3.47M | 2.36M | 1.48M | 602K | 337.4K | 307.4K | 251.4K |
Stock-Based Compensation | 4.33M | 5.47M | 5.5M | 3.65M | 4.45M | 5.05M | 6.31M | 7.36M | 8.12M | 9.88M | 11.42M | 13.69M | 19.67M | 16.49M | 15.11M | 11.89M | 3.57M |
Other Working Capital | -5.15M | -3.01M | -12.86M | 1.25M | 2.58M | 3.37M | 10.32M | 3.39M | 2.76M | -183K | -58K | -59K | -176K | -63K | 105.85K | 44.85K | 230.85K |
Other Non-Cash Items | 11.63M | 16.33M | 7.15M | 8.38M | 9.78M | 8.94M | 12.88M | 1.52M | -20.61M | -24.09M | -34.85M | -17.26M | 710K | 8.74M | 10.99M | 12M | 12.01M |
Deferred Income Tax | 1.67M | 1.65M | 825.99K | -1.47M | -2.6M | -3.08M | -4.19M | -4.21M | -3.99M | -4.34M | -2.46M | -1.86M | -957K | -119K | -1.56M | -2.52M | -2.51M |
Change in Working Capital | 7.87M | 9.15M | -16.94M | 116.86K | -798.73K | 6.17M | 14.48M | 25.84M | 16.35M | -5.52M | 53K | -20.41M | -18.94M | -7.18M | -7.91M | -8.33M | 1.38M |
Operating Cash Flow | -27.54M | -24.45M | -57.32M | -54.63M | -59.57M | -50.92M | -42.66M | -19.59M | -11.03M | -14.43M | -11.06M | -24.96M | -31.19M | -32.58M | -29.51M | -28.35M | -14.68M |
Capital Expenditures | 1.97M | 1.67M | 2.1M | -383.16K | -3.21M | -5.41M | -6.15M | -8.52M | -7.55M | -6.14M | -5.98M | -3.7M | -1.85M | -1.15M | -916.77K | -818.77K | -662.77K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 3.75K | 387.76K | 387.76K | 387.76K | 384.01K | 465.63 | 296.68K | 296.68K | 296.68K | 296.22K | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -2.56M | -2.56M | -7.97M | -5.41M | -5.41M | -5.41M | -3.75K | 239.58 | 239.58 | 239.58 | -11.76M | -11.77M | -12.06M | -12.06M | -296.68K | -296.22K | n/a |
Investing Cash Flow | -589.33K | -892.16K | -461.16K | -383.16K | -3.21M | -5.41M | -6.15M | -8.13M | -7.17M | -5.75M | -17.35M | -15.46M | -13.61M | -12.91M | -916.77K | -818.77K | -662.77K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | -1.54K | -864.75 | -864.75 | -159.86K | -158.33K | -159K | -159K | n/a | 16.27M | 16.27M | 16.27M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 467K | 465K | 465K | n/a | -63K | -147.68K | -146.14K | -146.14K | -83.09K | 1.59K | 296.05K | -1.44M | -2.2M | -2.64M | -2.73M | 23.97M | 24.72M |
Financial Cash Flow | 1.66M | 2.16M | 1.44M | 1.02M | 685.71K | 1.87M | 2.25M | 2.2M | 2.17M | 325.73K | -149.27K | -1.54M | 100.77M | 222.74M | 239.21M | 265.55M | 163.25M |
Net Cash Flow | -29.39M | -29.69M | -54.21M | -55.26M | -61.36M | -52.3M | -39.8M | -19.3M | -9.27M | -19.67M | -33.77M | -51.29M | 44.66M | 170.79M | 204.24M | 238.34M | 149.5M |
Free Cash Flow | -25.74M | -22.96M | -55.22M | -55.01M | -62.78M | -56.34M | -48.82M | -28.11M | -18.58M | -20.57M | -17.04M | -28.66M | -33.04M | -33.73M | -30.42M | -29.17M | -15.34M |